// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
The armed group have agreed to release the paramedics as soon as surgeries are organized on the territory of the seized patrol unit.
On the night of July 26-27, law enforcement authorities attacked the patrol department that an armed group has been holding for some 10 days.
“Artur Sargsyan broke through the police barricade to reach the entrance of the liberated area, with his car loaded with food,” the gunmen said.
Pavel Manukyan said the captives are treated well. He even joked that they won’t leave the police premises even if they are allowed to.
Partner news